Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BRID
BRID logo

BRID Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Bridgford Foods Corp (BRID) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
6.620
1 Day change
1.53%
52 Week Range
8.740
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

BRID is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading weakly with bearish moving averages, a negative MACD histogram, and no strong proprietary buy signal. With no recent news, no options edge, no insider or hedge fund accumulation, and no positive catalyst support, the setup does not justify an immediate buy for an impatient investor.

Technical Analysis

The trend is bearish. Price is 6.52, sitting below the pivot at 6.69 and near support at 6.445, with resistance at 6.935. The moving average structure is unfavorable with SMA_200 > SMA_20 > SMA_5, which is a classic downtrend alignment. MACD histogram is negative at -0.0159 and still contracting, confirming weak momentum. RSI_6 at 28.67 is low, but it has not translated into a clear reversal signal. Overall, the current trend points to continued weakness rather than a confirmed rebound.

Positive Catalysts

  • No recent news in the past week. No significant insider buying trend. No significant hedge fund accumulation. No recent congress trading data available. The only mildly positive element is that the stock is near short-term support, which could allow a small bounce, but it is not a strong catalyst.

Neutral/Negative Catalysts

  • Bearish technical structure, negative MACD, weak momentum, and lack of bullish proprietary signals. No news-driven catalyst. Hedge funds are neutral, insiders are neutral, and there is no congress trading support. The stock trend model also suggests downside pressure over the next month at -10.83%.

Financial Performance

No usable latest-quarter financial snapshot was provided, so there is no reliable quarterly growth assessment available. The latest quarter season cannot be confirmed from the data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no visible Wall Street upgrade/downgrade trend to support a bullish case. Based on the available data, Wall Street sentiment appears neutral to weak rather than constructive.

Wall Street analysts forecast BRID stock price to rise
Analyst Rating
0
Wall Street analysts forecast BRID stock price to rise
Buy
Hold
Sell
0
Current: 6.520
sliders
Low
0
Averages
0
High
0
0
Current: 6.520
sliders
Low
0
Averages
0
High
0
Wells Fargo
Tiago Fauth
Overweight
maintain
$84 -> $88
AI Analysis
2026-01-20
Reason
Wells Fargo
Tiago Fauth
Price Target
$84 -> $88
AI Analysis
2026-01-20
maintain
Overweight
Reason
Wells Fargo analyst Tiago Fauth raised the firm's price target on BridgeBio to $88 from $84 and keeps an Overweight rating on the shares. The firm notes Attruby revenues posted a solid Q4 beat, and Wells is raising its FY26 estimates by up 10%. The firm conservatively models some seasonality for Q1 but consistent quarter-over-quarter growth Q2-Q4 in 2026.
Truist
Buy
maintain
$80 -> $86
2026-01-08
Reason
Truist
Price Target
$80 -> $86
2026-01-08
maintain
Buy
Reason
Truist raised the firm's price target on BridgeBio to $86 from $80 and keeps a Buy rating on the shares. The firm updated its model, but tells investors in a research note that the fundamental views remain intact from 2025.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BRID
Unlock Now

People Also Watch